GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Revenue per Share

Delta-Fly Pharma (TSE:4598) Revenue per Share : 円0.00 (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Revenue per Share?

Delta-Fly Pharma's revenue per share for the three months ended in Dec. 2023 was 円0.00. Delta-Fly Pharma's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00.

During the past 12 months, the average Revenue Per Share Growth Rate of Delta-Fly Pharma was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Delta-Fly Pharma's Revenue per Share or its related term are showing as below:

During the past 7 years, Delta-Fly Pharma's highest 3-Year average Revenue Per Share Growth Rate was 5.10% per year. The lowest was -52.50% per year. And the median was -23.70% per year.

TSE:4598's 3-Year Revenue Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.65
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Delta-Fly Pharma Revenue per Share Historical Data

The historical data trend for Delta-Fly Pharma's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Revenue per Share Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Revenue per Share
Get a 7-Day Free Trial - 22.39 65.16 55.38 -

Delta-Fly Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Delta-Fly Pharma's Revenue per Share

For the Biotechnology subindustry, Delta-Fly Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delta-Fly Pharma's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's PS Ratio distribution charts can be found below:

* The bar in red indicates where Delta-Fly Pharma's PS Ratio falls into.



Delta-Fly Pharma Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Delta-Fly Pharma's Revenue Per Share for the fiscal year that ended in Mar. 2023 is calculated as

Revenue Per Share (A: Mar. 2023 )=Revenue (A: Mar. 2023 )/Shares Outstanding (Diluted Average) (A: Mar. 2023 )
=0/5.666
=0.00

Delta-Fly Pharma's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )=Revenue (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=0/8.230
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Delta-Fly Pharma  (TSE:4598) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Delta-Fly Pharma Revenue per Share Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Delta-Fly Pharma (TSE:4598) Business Description

Traded in Other Exchanges
N/A
Address
Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines